株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

閉塞性睡眠時無呼吸(OSA)- 疫学予測 2028年

Obstructive Sleep Apnea (OSA) - Epidemiology Forecast to 2028

発行 DelveInsight Business Research LLP 商品コード 736666
出版日 ページ情報 英文 99 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=107.66円で換算しております。
Back to Top
閉塞性睡眠時無呼吸(OSA)- 疫学予測 2028年 Obstructive Sleep Apnea (OSA) - Epidemiology Forecast to 2028
出版日: 2019年08月01日 ページ情報: 英文 99 Pages
概要

主要7カ国の閉塞性睡眠時無呼吸(OSA)の有病数は2017年に1億3,994万8,725人と推計されています。

当レポートでは、主要7カ国(米国、英国、ドイツ、フランス、イタリア、スペイン、日本)の閉塞性睡眠時無呼吸(OSA)について調査し、市場の概要、疾病背景、性別・重症度・国別の有病数の動向などについてまとめています。

目次

第1章 重要な洞察

第2章 閉塞性睡眠時無呼吸(OSA)市場の概要

  • 市場シェア(実績値)
  • 市場シェア(予測値)

第3章 閉塞性睡眠時無呼吸(OSA):疾病概要

  • イントロダクション
  • 重症度別の分類
  • 閉塞性睡眠時無呼吸(OSA)の臨床症状
  • 病因
  • 危険因子
  • 兆候と症状
  • 閉塞性睡眠時無呼吸(OSA)の病因
  • 診断
    • 診断基準
    • 小児閉塞性睡眠時無呼吸(OSA)の診断と管理

第4章 疫学と患者人口

  • 主な調査結果
  • 人口と予測パラメータ
  • 主要7カ国の閉塞性睡眠時無呼吸(OSA)有病率:年齢層別
  • 主要7カ国の成人閉塞性睡眠時無呼吸(OSA)の有病数

第5章 閉塞性睡眠時無呼吸(OSA)の疫学:国別

  • 米国
    • 仮定と根拠
    • OSA有病数:年齢層別
    • 成人OSA有病数
      • 総有病数
      • 有病数:性別
      • 有病数:重症度別
      • 臨床症状
      • 診断件数
  • 欧州5カ国
    • ドイツ
      • OSA有病数:年齢層別
      • 成人OSA有病数
    • フランス
    • イタリア
    • スペイン
    • 英国
  • 日本

第6章 付録

  • 調査方法

第7章 DelveInsightのサービス内容

第8章 免責事項

第9章 DelveInsightについて

図表

List of Tables

  • Table 1 Prevalent Population of Obstructive Sleep Apnea in the 7MM (2017-2028)
  • Table 2 Total Adult Cases of Obstructive Sleep Apnea in the 7MM (2017-2028)
  • Table 3 Age-specific Prevalent Cases of Obstructive Sleep Apnea in the United States (2017-2028)
  • Table 4 Prevalence of OSA in Adults in the United States (2017-2028)
  • Table 5 Gender-specific Prevalence of Obstructive Sleep Apnea in the United States (2017-2028)
  • Table 6 Severity-specific Prevalent Cases of Obstructive Sleep Apnea in the United States (2017-2028)
  • Table 7 Prevalence of Clinical Manifestation of OSA in Adults in the United States (2017-2028)
  • Table 8 Diagnosed Cases of Obstructive Sleep Apnea in the United States (2017-2028)
  • Table 9 Prevalence of Obstructive Sleep Apnea in Germany by Age-group (2017-2028)
  • Table 10 Total Prevalence of Obstructive Sleep Apnea in Adults in Germany (2017-2028)
  • Table 11 Gender-specific Prevalence of Obstructive Sleep Apnea in Adults in Germany (2017-2028)
  • Table 12 Severity-specific prevalent cases of Obstructive Sleep Apnea in Germany (2017-2028)
  • Table 13 Prevalence of Clinical Manifestation of OSA in Adults in Germany (2017-2028)
  • Table 14 Diagnosed Cases of Obstructive Sleep Apnea in Germany (2017-2028)
  • Table 15 Age-specific Prevalence of Obstructive Sleep Apnea in France (2017-2028)
  • Table 16 Total Prevalence of Obstructive Sleep Apnea in France (2017-2028)
  • Table 17 Gender-specific Prevalent Cases of Obstructive Sleep Apnea in France (2017-2028)
  • Table 18 Severity Specific Prevalence of Obstructive Sleep Apnea in France (2017-2028)
  • Table 19 Prevalence of Clinical Manifestation of OSA in Adults in France (2017-2028)
  • Table 20 Diagnosed Cases of Obstructive Sleep Apnea in France (2017-2028)
  • Table 21 Prevalent Cases of Obstructive Sleep Apnea By Age-group in Italy (2017-2028)
  • Table 22 Total Prevalence of Obstructive Sleep Apnea in Adults in Italy (2017-2028)
  • Table 23 Gender-specific Prevalence of Obstructive Sleep Apnea in Italy (2017-2028)
  • Table 24 Severity-specific Prevalent Cases of Obstructive Sleep Apnea in Italy (2017-2028)
  • Table 25 Prevalence of Clinical Manifestation of OSA in Adults in Italy (2017-2028)
  • Table 26 Diagnosed Cases of Obstructive Sleep Apnea in Italy (2017-2028)
  • Table 27 Prevalent Cases of Obstructive Sleep Apnea by Age-group in Spain (2017-2028)
  • Table 28 Total Prevalence of Obstructive Sleep Apnea in Adults in Spain (2017-2028)
  • Table 29 Gender-specific Prevalence of Obstructive Sleep Apnea in Spain (2017-2028)
  • Table 30 Severity-specific Prevalent Cases of Obstructive Sleep Apnea in Spain (2017-2028)
  • Table 31 Prevalence of Clinical Manifestation of OSA in Adults in Spain (2017-2028)
  • Table 32 Diagnosed Cases of Obstructive Sleep Apnea in Spain (2017-2028)
  • Table 33 Prevalent Cases of Obstructive Sleep Apnea by Age-group in the United Kingdom (2017-2028)
  • Table 34 Total Prevalence of Obstructive Sleep Apnea in Adults the United Kingdom (2017-2028)
  • Table 35 Gender-specific Prevalence of OSA in the United Kingdom (2017-2028)
  • Table 36 Severity-specific Prevalent Cases of Obstructive Sleep Apnea in the UK (2017-2028)
  • Table 37 Prevalence of Clinical Manifestation of OSA in Adults in the UK (2017-2028)
  • Table 38 Diagnosed Cases of Obstructive Sleep Apnea in the United Kingdom(2017-2028)
  • Table 39 Age-Group Specific Prevalence of Obstructive Sleep Apnea in Japan (2017-2028)
  • Table 40 Total Prevalence of Obstructive Sleep Apnea in Adults Japan (2017-2028)
  • Table 41 Gender-specific Prevalence of Obstructive Sleep Apnea in Japan (2017-2028)
  • Table 42 Severity-specific Prevalent Cases of Obstructive Sleep Apnea in Japan (2017-2028)
  • Table 43 Prevalence of Clinical Manifestation of OSA in Adults in Japan (2017-2028)
  • Table 44 Diagnosed Cases of Obstructive Sleep Apnea in Japan (2017-2028)

List of Figures

  • Figure 1 Airway obstruction in Sleep Apnea
  • Figure 2 Apnea / hypopnea cycle
  • Figure 3 Pathological relationship between sleep apnea and cardiovascular disease
  • Figure 4 Risk Factors for Obstructive Sleep Apnea
  • Figure 5 Clinical algorithm for implementation of clinical practice guidelines.
  • Figure 6 Prevalent Population of Obstructive Sleep Apnea in the 7MM (2017-2028)
  • Figure 7 Total Adult OSA Cases in 7MM (2017-2028)
  • Figure 8 Prevalence of Obstructive Sleep Apnea by Age Group in the United States (2017-2028)
  • Figure 9 Prevalence of OSA in Adults in the United States (2017-2028)
  • Figure 10 Gender Specific Prevalence of Obstructive Sleep Apnea in the United States (2017-2028)
  • Figure 11 Severity-specific Prevalent Cases of Obstructive Sleep Apnea in the US (2017-2028)
  • Figure 12 Prevalence of Clinical Manifestation of OSA in Adults in the United States (2017-2028)
  • Figure 13 Diagnosed Cases of Obstructive Sleep Apnea in the United States (2017-2028)
  • Figure 14 Prevalence of Obstructive Sleep Apnea in Germany by Age Group (2017-2028)
  • Figure 15 Total Prevalence of Obstructive Sleep Apnea in Adults in Germany (2017-2028)
  • Figure 16 Gender Specific Prevalence of Obstructive Sleep Apnea in Adults in Germany (2017-2028)
  • Figure 17 Severity specific prevalent cases of Obstructive Sleep Apnea in Germany (2017-2028)
  • Figure 18 Prevalence of Clinical Manifestation of OSA in Adults in Germany (2017-2028)
  • Figure 19 Diagnosed Cases of Obstructive Sleep Apnea in Germany (2017-2028)
  • Figure 20 Prevalence of Obstructive Sleep Apnea in France by Age Group (2017-2028)
  • Figure 21 Total Prevalence of Obstructive Sleep Apnea in Adults in France (2017-2028)
  • Figure 22 Gender-specific Prevalent Cases of Obstructive Sleep Apnea in France (2017-2028)
  • Figure 23 Severity Specific Prevalence of Obstructive Sleep Apnea in France (2017-2028)
  • Figure 24 Prevalence of Clinical Manifestation of OSA in Adults in France (2017-2028)
  • Figure 25 Diagnosed Cases of Obstructive Sleep Apnea in France (2017-2028)
  • Figure 26 Prevalent Cases of Obstructive Sleep Apnea By Age Group in Italy (2017-2028)
  • Figure 27 Total Prevalence of Obstructive Sleep Apnea in Adults in Italy (2017-2028)
  • Figure 28 Gender-specific Prevalence of Obstructive Sleep Apnea in Italy (2017-2028)
  • Figure 29 Severity specific Prevalent Cases of Obstructive Sleep Apnea in Italy (2017-2028)
  • Figure 30 Prevalence of Clinical Manifestation of OSA in Adults in Italy (2017-2028)
  • Figure 31 Diagnosed Cases of Obstructive Sleep Apnea in Italy (2017-2028)
  • Figure 32 Prevalence of Obstructive Sleep Apnea by Age Group in Spain (2017-2028)
  • Figure 33 Total Prevalence of Obstructive Sleep Apnea in Adults in Spain (2017-2028)
  • Figure 34 Gender Specific Prevalence of Obstructive Sleep Apnea in Spain (2017-2028)
  • Figure 35 Severity specific Prevalent Cases of Obstructive Sleep Apnea in Spain (2017-2028)
  • Figure 36 Prevalence of Clinical Manifestation of OSA in Adults in Spain (2017-2028)
  • Figure 37 Diagnosed Cases of Obstructive Sleep Apnea in Spain (2017-2028)
  • Figure 38 Prevalent Cases of Obstructive Sleep Apnea in the United Kingdom (2017-2028)
  • Figure 39 Total Prevalence of Obstructive Sleep Apnea in Adults the United Kingdom (2017-2028)
  • Figure 40 Gender Specific Prevalence of OSA in the United Kingdom (2017-2028)
  • Figure 41 Severity specific Prevalent Cases of Obstructive Sleep Apnea in the UK (2017-2028)
  • Figure 42 Prevalence of Clinical Manifestation of OSA in Adults in the UK (2017-2028)
  • Figure 43 Diagnosed Cases of Obstructive Sleep Apnea in the United Kingdom (2017-2028)
  • Figure 44 Age Group Specific Prevalence of Obstructive Sleep Apnea in Japan (2017-2028)
  • Figure 45 Total Prevalence of Obstructive Sleep Apnea in Adults Japan (2017-2028)
  • Figure 46 Gender Specific Prevalence of Obstructive Sleep Apnea in Japan (2017-2028)
  • Figure 47 Severity specific Prevalent Cases of Obstructive Sleep Apnea in Japan (2017-2028)
  • Figure 48 Prevalence of Clinical Manifestation of OSA in Adults in Japan (2017-2028)
  • Figure 49 Diagnosed Cases of Obstructive Sleep Apnea in Japan (2017-2028)
目次
Product Code: DIEI0361

DelveInsight's 'Obstructive Sleep Apnea (OSA)- Epidemiology Forecast to 2028' report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Obstructive Sleep Apnea in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.

Geography Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain and the United Kingdom)
  • Japan

Study Period: 2017-2028

Obstructive Sleep Apnea Epidemiology

The Obstructive Sleep Apnea (OSA) epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. The epidemiology data for Obstructive Sleep Apnea are studied through all possible division to give a better understanding about the Disease scenario in 7MM. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Obstructive Sleep Apnea Epidemiology Segmentation

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology (total prevalent cases by age-group, adult prevalent cases, gender-specific prevalent cases in adults, severity-specific prevalent cases in adults, clinical manifestations in adults and diagnosed cases of OSA in adults) scenario of Obstructive Sleep Apnea (OSA) in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2017-2028.

The DelveInsight report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

According to DelveInsight, the total number of prevalent cases of Obstructive Sleep Apnea (OSA) in 7 MM was found to be 139,948,725, in the year 2017.

Report Scope

  • The report covers detailed overview of Obstructive Sleep Apnea explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The report provides the insight about the historical and forecasted patient pool of Obstructive Sleep Apnea in 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
  • The Report assesses the disease risk and burden and highlights the unmet needs of the disease
  • The Report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report provides the segmentation of the disease epidemiology by prevalence of all age-groups, prevalence in adults, gender based prevalence in adults, severity based prevalent cases in adults, clinical manifestations in adults and diagnosed cases in adults in 7MM

Key strengths

  • 10 Year Forecast of Obstructive Sleep Apnea epidemiology
  • 7MM Coverage
  • Total Prevalent Cases of OSA
  • Prevalent Cases according to segmentation: Prevalence, Types, Age Groups, Severity and segments based gender.
  • Diagnosed cases of OSA

Key assessments

  • Patient Segmentation
  • Disease Risk & Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

Table of Contents

1. Key Insights

2. Obstructive Sleep Apnea (OSA) Market Overview at a Glance

  • 2.1. Market Share (%) Distribution of OSA in 2017
  • 2.2. Market Share (%) Distribution of OSA in 2028

3. Obstructive Sleep Apnea (OSA): Disease Overview

  • 3.1. Introduction
  • 3.2. Severity Based Classification
  • 3.3. Clinical Manifestations of Obstructive Sleep Apnea
  • 3.4. Etiology
  • 3.5. Risk Factors
  • 3.6. Signs and Symptoms
  • 3.7. Pathogenesis of Obstructive Sleep Apnea
  • 3.8. Diagnosis
    • 3.8.1. Diagnostic Criteria
    • 3.8.2. Diagnosis and Management of Childhood Obstructive Sleep Apnea Syndrome

4. Epidemiology and Patient Population

  • 4.1. Key Findings
  • 4.2. Population and Forecast Parameters
  • 4.3. Prevalence of OSA by Age Group in 7MM
  • 4.4. Total Prevalence of OSA in Adults in 7MM

5. Country Wise-Epidemiology of Obstructive Sleep Apnea

  • 5.1. United States
    • 5.1.1. Assumptions and Rationale
    • 5.1.2. Prevalence of OSA by Age Group in the United States
    • 5.1.3. Prevalence of OSA in Adults in the US
      • 5.1.3.1. Total Prevalence of OSA in the US
      • 5.1.3.2. Gender Specific Prevalence of OSA in the US
      • 5.1.3.3. Severity-specific Prevalent Cases of OSA in the US
      • 5.1.3.4. Clinical Manifestations of OSA in the US
      • 5.1.3.5. Diagnosed cases of OSA in Adult Population in the US
  • 5.2. EU5 Countries
    • 5.2.1. Germany
    • 5.2.2. Prevalence of OSA by Age Group in Germany
    • 5.2.3. Prevalence of OSA in Adults in Germany
      • 5.2.3.1. Total Prevalence of OSA in Germany
      • 5.2.3.2. Gender Specific Prevalence of OSA in Germany
      • 5.2.3.3. Severity-specific Prevalent Cases of OSA in Germany
      • 5.2.3.4. Clinical Manifestations of OSA in Germany
      • 5.2.3.5. Diagnosed cases of OSA in Adult Population in Germany
  • 5.3. France
    • 5.3.1. Prevalence of OSA by Age Group in France
    • 5.3.2. Prevalence of OSA in Adults in France
      • 5.3.2.1. Total Prevalence of OSA in France
      • 5.3.2.2. Gender-specific Prevalence of OSA in France
      • 5.3.2.3. Severity-specific Prevalent Cases of OSA in France
      • 5.3.2.4. Clinical Manifestations of OSA in France
      • 5.3.2.5. Diagnosed cases of OSA in Adult Population in France
  • 5.4. Italy
    • 5.4.1. Prevalence of OSA by Age Group in Italy
    • 5.4.2. Prevalence of OSA in Adults in Italy
      • 5.4.2.1. Total Prevalence of OSA in Italy
      • 5.4.2.2. Gender-specific Prevalence of OSA in Italy
      • 5.4.2.3. Severity-specific Prevalence of OSA in Italy
      • 5.4.2.4. Clinical Manifestations of OSA in Italy
      • 5.4.2.5. Diagnosed cases of OSA in Adult Population in Italy
  • 5.5. Spain
    • 5.5.1. Prevalence of OSA by Age Group in Spain
    • 5.5.2. Prevalence of OSA in Adults in Spain
      • 5.5.2.1. Total Prevalence of OSA in Spain
      • 5.5.2.2. Gender-specific Prevalence of OSA in Spain
      • 5.5.2.3. Severity-specific Prevalence of OSA in Spain
      • 5.5.2.4. Clinical Manifestations of OSA in Spain
      • 5.5.2.5. Diagnosed cases of OSA in Adult Population in Spain
  • 5.6. United Kingdom
    • 5.6.1. Prevalence of OSA by Age Group in the United Kingdom
    • 5.6.2. Prevalence of OSA in Adults in the United Kingdom
      • 5.6.2.1. Total Prevalence of OSA in the United Kingdom
      • 5.6.2.2. Gender-specific Prevalence of OSA in United Kingdom
      • 5.6.2.3. Severity-specific Prevalence of OSA in the United Kingdom
      • 5.6.2.4. Clinical Manifestations of OSA in United Kingdom
      • 5.6.2.5. Diagnosed cases of OSA in Adult Population in the UK
  • 5.7. Japan
    • 5.7.1. Prevalence of OSA by Age Group in Japan
    • 5.7.2. Prevalence of OSA in Adults in Japan
      • 5.7.2.1. Total Prevalence of OSA in Japan
      • 5.7.2.2. Gender-specific Prevalence of OSA in Japan
      • 5.7.2.3. Severity-specific Prevalence of OSA in Japan
      • 5.7.2.4. Clinical Manifestations of OSA in Japan
      • 5.7.2.5. Diagnosed cases of OSA in Adult Population in Japan

6. Appendix

  • 6.1. Report Methodology

7. DelveInsight Capabilities

8. Disclaimer

9. About DelveInsight

Back to Top